• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ORISE GEL; SUBMUCOSAL INJECTION AGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ORISE GEL; SUBMUCOSAL INJECTION AGENT Back to Search Results
Model Number M00519221
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Inflammation (1932)
Event Date 04/01/2022
Event Type  Injury  
Manufacturer Narrative
The complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.Date of event: the exact date of the event is unknown.It was reported that the esd procedure was performed in april 2022.The provided event date was chosen as a best estimate.
 
Event Description
It was reported to boston scientific corporation that orise gel was used in the duodenum during an endoscopic submucosal dissection (esd) procedure performed in (b)(6) 2021.In (b)(6) 2022, a positron emission tomography (pet) scan was performed to evaluate a lung nodule for a separate issue.The pet scan showed a "hot spot" in the duodenum at the same location as the esd performed in (b)(6) 2021.It was stated that the physician attributed this finding to orise inflammation.As a result of the findings on the pet scan, the patient underwent an esophagogastroduodenoscopy (egd) procedure with biopsy in (b)(6) 2022.The biopsy showed "peptic duodenitis with ulceration".
 
Manufacturer Narrative
Block d4 and h4: the complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.Block b3: the exact date of the event is unknown.It was reported that the esd procedure was performed in (b)(6) 2022.The provided event date was chosen as a best estimate.Block h11: blocks d4, h6 (evaluation method codes, evaluation method codes and evaluation conclusion codes) have been corrected.
 
Event Description
It was reported to boston scientific corporation that orise gel was used in the duodenum during an endoscopic submucosal dissection (esd) procedure performed in (b)(6) 2021.In february 2022, a positron emission tomography (pet) scan was performed to evaluate a lung nodule for a separate issue.The pet scan showed a "hot spot" in the duodenum at the same location as the esd performed in (b)(6) 2021.It was stated that the physician attributed this finding to orise inflammation.As a result of the findings on the pet scan, the patient underwent an esophagogastroduodenoscopy (egd) procedure with biopsy in (b)(6) 2022.The biopsy showed "peptic duodenitis with ulceration".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORISE GEL
Type of Device
SUBMUCOSAL INJECTION AGENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
model farm road
cork
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key15655131
MDR Text Key302247423
Report Number3005099803-2022-06082
Device Sequence Number1
Product Code PLL
UDI-Device Identifier08714729993841
UDI-Public08714729993841
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K180068
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Notification
Type of Report Initial,Followup
Report Date 11/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM00519221
Device Catalogue Number2202-03
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/26/2022
Initial Date FDA Received10/21/2022
Supplement Dates Manufacturer Received11/03/2022
Supplement Dates FDA Received11/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number92926415-FA
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-